A Study of Pertuzumab in Participants With Metastatic Breast Cancer

NCT02491892 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
79
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche